vaccines

AMA Update 134: BA.2 variant, boosters & U.S. case reporting changes with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 news and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering what we know about the BA.2 Omicron subvariant, if a new surge is coming soon, the latest on booster shots and changing data collection on the pandemic.

Read More

AMA Update 132: AMA President Gerald Harmon, MD, on fixing our health system and rebuilding trust

AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares five actions we can take now to fix our ailing health care system and rebuild trust.

Read More

AMA Update 102: Paul Offit, MD, discusses the importance of pediatric COVID vaccination

AMA CXO Todd Unger talks with Paul Offit, MD, the director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia, about pediatric COVID vaccination, mandates and boosters.

Read More

AMA Update 101: Andrea Garcia, JD, MPH, discusses uptick in COVID cases and flu outbreaks

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on COVID-19 treatment pills, expanding eligibility for booster shots, what the uptick in cases in Europe could forecast for the U.S., as well as flu outbreaks and press releases from the November 2021 Special Meeting of the AMA House of Delegates.

Read More

AMA Update 95: Andrea Garcia, JD, MPH, discusses vaccine authorization for 5-11 year olds

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster news and current vaccine timeline for the 5 to 11 year old age group.

Read More

AMA Update 94: Dr. Sandra Fryhofer shares the latest on boosters and the new «mix-and-match strategy»

AMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

Read More

AMA Update 93: Andrea Garcia, JD, MPH, discusses boosters and pending authorizations

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster shots (including FDA and CDC recommendations), COVID case spikes related to dropping temperatures, and a reminder to get your annual flu shot.

Read More

AMA Update 92: CDC’s Dr. Alex Kallen discusses what physicians need to know about infection prevention and control

AMA CXO Todd Unger talks with the CDC’s Dr. Alex Kallen, chief of the Prevention and Response Branch in the Division of Healthcare Quality Promotion, about the importance of infection prevention and control and what physicians need to know about updated guidance in this area.  

Read More

AMA Update 91: Andrea Garcia, JD, MPH, discusses EUA requests for boosters and children ages 5-11

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID-19 vaccine emergency use authorization (EUA) requests from Pfizer for children ages 5-11, as well as movement on boosters for Johnson & Johnson and Moderna vaccine recipients.

Read More

AMA Update 89: Andrea Garcia, JD, MPH, discusses trends and urgent call for pregnant people to get vaccinated

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering movement on FDA’s J&J and Moderna booster EUA consideration, New York’s vaccine mandate, and Merck’s antiviral COVID-19 treatment pill.

Read More